Hims & Hers Expands Global Footprint with Eucalyptus Acquisition — Hims & Hers Health, Inc.

Event summary

Hims & Hers completed the acquisition of Eucalyptus on June 2, 2026, solidifying its position as the world’s largest consumer health platform.
The acquisition adds Eucalyptus’s 850,000 customers and deepens Hims & Hers’ presence in the US, UK, Australia, Canada, France, Germany, Ireland, Spain, and Japan.
Hims & Hers aims to reach hundreds of millions of people across four continents, leveraging data and local clinical expertise to deliver personalized care.
The company reaffirmed its long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.

The big picture

Hims & Hers’ acquisition of Eucalyptus underscores the accelerating consolidation in the digital health sector, as companies race to build scalable, data-driven platforms. The move positions Hims & Hers to compete with traditional healthcare providers by offering personalized, high-touch care globally. The company’s ambitious revenue targets hinge on its ability to integrate these acquisitions seamlessly and maintain operational efficiency across diverse markets.

What we're watching

Integration Challenges: How Hims & Hers will manage the operational and cultural integration of Eucalyptus, ZAVA, and Livewell into its existing platform.
Regulatory Compliance: Whether the company can navigate varying healthcare regulations across its expanded global markets.
Revenue Growth: The pace at which Hims & Hers can convert its expanded customer base into sustainable revenue growth.